HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 22, No 01, January 2018 – Weighing the options       » Scientists close in on origin of SARS       » Chinese researchers map key protein in DNA repair with near-atomic resolution       » Ryzodeg reduces hypoglycaemia in type 2 diabetic fasting patients       » United States cancer drug costs increasing despite competition       » Eating yogurt may help reduce chronic inflammation in women      
INSIDE INDUSTRY
Verisante Aura named finalist for 2013 SPIE Prism Award
Verisante Technology Inc., a company that deals with cancer detection technology, has announced that Verisante's Aura™ — the revolutionary skin cancer detection device — has been named a finalist for the 2013 Prism Awards in the Life Sciences and Biophotonics category.

“We are honored to be a finalist for this prestigious Award,” said Thomas Braun, President and CEO. “It is very gratifying to be recognized as an industry leader for our innovative and disruptive technology, which has the potential to improve patient outcomes, reduce wait times and also save the health care system time and money. The Aura is a game changing technology because in half a second it will tell doctors if a suspicious skin lesion is high or low risk for being cancerous and should be biopsied or not.”

The Verisante Aura™ beta units are currently installed at five leading dermatology clinics across Canada for software verification purposes. This is the final step prior to making this device available in Canada, 27 European countries, and Australia where the device has already been approved for sale. The Verisante Aura™ is expected to be commercially available in Canada, Europe and Australia in early 2013.

The Prism Awards, named the “Photonics Oscar” by OptecNet Deutschland, is a celebration of the best of the industry. It takes place every year in conjunction with SPIE Photonics West in San Francisco, California.

The Prism Awards for Photonics Innovation is a leading international competition that honors the best new photonic products on the market. Over the years, the Prism Awards has received applications from more than 35 countries across the globe. Applications are judged by panel of leading industry experts, venture capitalists, luminaries and visionaries.

SPIE Photonics West is the world's largest and most influential photonics and optics event with over 1500 companies exhibiting and 20,000 attendees.

Click here for the complete issue.

NEWS CRUNCH  
news Biology of Ageing II - Impactful Interventions
news Separation of conjoined twins presents surgical and ethical challenges for MassGeneral Hospital for Children staff
news MIT Technology Review announces 2018's 10 'Innovators Under 35 Asia'
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Addressing the ageing population / Clinical trials
March:
Nutrition / Women in Science
April:
Digestive health / Intellectual property
May:
Asthma / Dental health
June:
Oncology / Biotech landscape in APAC
July:
Water management / Vaccination
August:
Regenerative medicine / Biotech start ups
September:
Digital healthcare / 3D printing
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy